EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis

David Scholten, Lamiaa El-Shennawy, Yuzhi Jia, Youbin Zhang, Elizabeth Hyun, Carolina Reduzzi, Andrew D Hoffmann, Hannah F Almubarak, Fangjia Tong, Nurmaa K Dashzeveg, Yuanfei Sun, Joshua R Squires und 7 weitere

Journal of Clinical Investigation · 16.09.2025 · 135 (18)

DOI: 10.1172/jci193521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.09.2025. Verfasst von David Scholten und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immune ecosystem is central to maintaining effective defensive responses. However, it remains largely understudied how immune cells in the peripheral blood interact with circulating tumor cells (CTCs) in metastasis. Here, blood analysis of patients with advanced breast cancer revealed that over 75% of CTC-positive blood specimens contained heterotypic CTC clusters with CD45 + white blood cells (WBCs), which correlates with breast cancer subtypes, racial groups, and decreased survival. CTC-WBC clusters included overrepresented T cells and underrepresented neutrophils. Specifically, a rare subset of CD4 and CD8 double-positive T (DPT) cells was 140-fold enriched in CTC clusters versus their frequency in WBCs. DPT cells shared properties with CD4 + and CD8 + T cells but exhibited unique features of T cell exhaustion and immune suppression. Mechanistically, the integrin heterodimer α4β1, also named very late antigen 4 (VLA-4), in DPT cells and its ligand, VCAM1, in tumor cells are essential mediators of DPT-CTC clusters. Neoadjuvant administration of anti-VLA-4 neutralizing antibodies markedly blocked CTC–DPT clusters, inhibited metastasis, and extended mouse survival. These findings highlight a pivotal role of rare DPT cells in fostering cancer dissemination through CTC clustering. It lays a foundation for developing innovative biomarker-guided therapeutic strategies to prevent and target cancer metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingBreast NeoplasmsCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesHumansFemaleAnimalsMiceNeoplasm MetastasisIntegrin alpha4beta1Vascular Cell Adhesion Molecule-1Cell Line, Tumor

Stichwörter der Autor:innen

Breast cancerClinical ResearchDiagnosticsImmunologyOncologyT cells

Substanzen

Integrin alpha4beta1Vascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Department of Pharmacology.
  • Driskill Graduate Program in Life Sciences.
  • Division of Hematology and Oncology, Department of Medicine, and.
  • Circulating Tumor Cell Core, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell School of Medicine, New York, New York, USA.
  • Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • American Cancer Society
  • Chan Zuckerberg Initiative
  • U.S. Department of Defense
  • Lynn Sage Cancer Research Foundation

Zitieren

APA

Scholten, D., El-Shennawy, L., Jia, Y., Zhang, Y., Hyun, E., Reduzzi, C., Hoffmann, A. D., Almubarak, H. F., Tong, F., Dashzeveg, N. K., Sun, Y., Squires, J. R., Lu, J., Platanias, L. C., Wasserfall, C. H., Gradishar, W. J., Cristofanilli, M., Fang, D., & Liu, H. (2025). Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. Journal of Clinical Investigation, 135(18). https://doi.org/10.1172/jci193521

Vancouver

Scholten D, El-Shennawy L, Jia Y, Zhang Y, Hyun E, Reduzzi C, et al. Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. Journal of Clinical Investigation. 2025;135(18). doi:10.1172/jci193521

BibTeX
@article{Scholten2025,
  author = {Scholten, David and El-Shennawy, Lamiaa and Jia, Yuzhi and Zhang, Youbin and Hyun, Elizabeth and Reduzzi, Carolina and Hoffmann, Andrew D and Almubarak, Hannah F and Tong, Fangjia and Dashzeveg, Nurmaa K and Sun, Yuanfei and Squires, Joshua R and Lu, Janice and Platanias, Leonidas C and Wasserfall, Clive H and Gradishar, William J and Cristofanilli, Massimo and Fang, Deyu and Liu, Huiping},
  title = {Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {18},
  doi = {10.1172/jci193521}
}
Kostenlos starten →